Prescription drug · NDA AUTHORIZED GENERIC
Liothyronine Sodium NDC 59762-1207
Liothyronine sodium 25 ug/1 · Tablet · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59762-1207-1 | 59762120701 | 100 TABLET in 1 BOTTLE (59762-1207-1)Marketed from Jun 24, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Liothyronine Sodium
- Generic name (nonproprietary)
- liothyronine sodium
- Active ingredients
- Liothyronine sodium — 25 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 59762
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 010379
- Marketing start
- Listing expires
- Other FDA classes
- Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 59762-1207_4f442ced-f23b-4005-95e2-4ce01636ac19SPL ID 4f442ced-f23b-4005-95e2-4ce01636ac19SPL set ID 115a84c2-0126-4dd7-816e-1873875f1e49RxCUI 903456, 903697, 903703UNII GCA9VV7D2NUPC 0359762120618
- Pharmacologic class
- l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459762120701followed by a unit qualifier and the quantityPackage 59762-1207-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Liothyronine sodium is an L-triiodothyronine (T3) indicated for: • Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( 1.1 ) • Pituitary Thyroid-Stimulating Hormone (TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) • Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use : - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not indica…
Excerpt only. Read the full label for complete information.
About NDC 59762-1207
- What is NDC 59762-1207?
- 59762-1207 is the product NDC for Liothyronine Sodium, Liothyronine sodium 25 ug/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Liothyronine Sodium.
- What is the active ingredient?
- Liothyronine sodium.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Liothyronine Sodium?
- 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Liothyronine Sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-001 | 75907-0001-01 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-004 | 75907-0004-01 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-039 | 75907-0039-01 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-114 | 70377-0114-1170377-0114-1270377-0114-13 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-115 | 70377-0115-1170377-0115-1270377-0115-13 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-116 | 70377-0116-1170377-0116-1270377-0116-13 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Northstar Rx LLC | 16714-166 | 16714-0166-01 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Northstar Rx LLC | 16714-167 | 16714-0167-01 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Northstar Rx LLC | 16714-168 | 16714-0168-01 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-2178 | 00093-2178-01 |
Other NDCs under NDA 010379
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cytomelliothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-115 |
| Cytomelliothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-116 |
| Cytomelliothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-117 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1206 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1208 |